FDA Inspection
Abbvie Biotechnology Ltd.Abbvie Biotechnology Ltd. – FDA Inspection, Mar 25, 2019
Record Details
This FDA Inspection record concerns Abbvie Biotechnology Ltd., with an inspection on March 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 8a1c2a7f-d230-419e-8259-9a4045db92d1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1084057
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Abbvie Biotechnology Ltd.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2026 | Not classified | San Juan District Office | Drug Quality Assurance |
| October 30, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 13, 2017 | Not classified | San Juan District Office |
Other documents for Abbvie Biotechnology Ltd.
- FDA Inspection 1321476 - 2026-06-10
- FDA Inspection 1222107 - 2023-10-30
- FDA Inspection 1055102 - 2018-06-01
- FDA Inspection 1012249 - 2017-04-28
- FDA Inspection 1001477 - 2017-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.